---
title: Ectopic HCN4 Provides a Target Biomarker for the Genetic Spectrum of mTORopathies
date: '2024-03-18'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38496361/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240318180755&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'BACKGROUND AND OBJECTIVES: Pathogenic variants in PI3K-AKT-mTOR pathway
  and GATOR1 complex genes resulting in hyperactivation of mechanistic target of rapamycin
  (mTOR) complex 1 are a major cause of drug-resistant epilepsy and focal cortical
  malformations (FCM). Resective neurosurgery is often required to achieve seizure
  control in patients with mTORopathies due to lack of effectiveness of nonsurgical
  therapies, including antiseizure medication and mTOR inhibitors. ...'
disable_comments: true
---
BACKGROUND AND OBJECTIVES: Pathogenic variants in PI3K-AKT-mTOR pathway and GATOR1 complex genes resulting in hyperactivation of mechanistic target of rapamycin (mTOR) complex 1 are a major cause of drug-resistant epilepsy and focal cortical malformations (FCM). Resective neurosurgery is often required to achieve seizure control in patients with mTORopathies due to lack of effectiveness of nonsurgical therapies, including antiseizure medication and mTOR inhibitors. ...